Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04774029 · ClinicalTrials.gov registry record · Early Phase 1
Basivertebral Nerve Block During Vertebral Augmentation: An Alternative Approach to Intraprocedural Pain Management
A Early Phase 1 study of Vertebral Fracture and Vertebral Compression, sponsored by Northwell Health.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT04774029 is a Early Phase 1 study of Vertebral Fracture and Vertebral Compression that has completed, run by Northwell Health. The registered enrollment target is 10 participants, below the 39-participant average among 3 other Vertebral Fracture trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04774029, a Early Phase 1 study of Vertebral Fracture and Vertebral Compression, has completed, sponsored by Northwell Health.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to assess the efficacy of lidocaine basivertebral nerve block as intraprocedural anesthesia during vertebral augmentation procedures.
Conditions Studied
Interventions
- PROCEDURE Basivertebral nerve block
- DRUG Lidocaine induced basivertebral nerve block
Study Locations (1)
New York
- Northwell Health Mather Hospital - Port Jefferson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2020-01-10 |
| Est. Completion | 2020-05-01 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04774029
The ClinicalTrials.gov registry entry for NCT04774029 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 39-participant average among 3 other Vertebral Fracture trials with a reported enrollment target (74% lower). The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Vertebral Fracture appearing as the primary indexed condition, and to 2 interventions - of which Basivertebral nerve block is the first listed.
NCT04774029 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT04774029 about?
NCT04774029 is a clinical study titled "Basivertebral Nerve Block During Vertebral Augmentation: An Alternative Approach to Intraprocedural Pain Management". The goal of this study is to assess the efficacy of lidocaine basivertebral nerve block as intraprocedural anesthesia during vertebral augmentation procedures.
What is the current status of trial NCT04774029?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 10 participants. The study started on 2020-01-10. Estimated completion is 2020-05-01.
What conditions does trial NCT04774029 study?
This clinical trial studies the following conditions: Vertebral Fracture, Vertebral Compression, Vertebra Compression Fracture.
What interventions are being tested in trial NCT04774029?
The interventions under investigation include: Basivertebral nerve block (PROCEDURE), Lidocaine induced basivertebral nerve block (DRUG).
Who is sponsoring clinical trial NCT04774029?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04774029 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Vertebral Fracture
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.